Speculum AB
ActiveKey figures
Key figures
2025Summary: Speculum AB
What kind of company is it?
Speculum AB (org. no. 559287-0447) is a limited company (AB). The company was registered in 2020 and has existed for 5 years. Registered seat: Eskilstuna. Industry according to Statistics Sweden: specialist medical practice activities, not at hospitals (SNI 86222).
How is the company doing financially?
Net sales in financial year 2025 were 4 066 000 kr, down 0,6 % on the previous year (4 092 000 kr). From 2023 to 2025, net sales grew by an average of 1,4 % per year. Net profit for 2025 was 255 194 kr (6,3 % of net sales). The company was profitable in all 3 reported financial years. Employees in financial year 2025: 2. Net sales per employee were 2 033 000 kr. At the end of financial year 2025, total assets were 1 432 246 kr and equity 621 066 kr (equity ratio 43,4 %). The annual report for 2025 proposes a dividend of 300 000 kr.
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 2 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 300 000 kr.
Summary of annual reports2023–2025
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Sales revenue | 3 951 000 | 4 092 000 | 4 066 000 |
| Profit for the reporting year | 438 852 | 980 594 | 255 194 |
| Retained earnings of previous periods | — | — | — |
| Total assets | 1 210 112 | 2 438 196 | 1 432 246 |
| Total liabilities | 574 834 | 1 072 324 | 811 180 |
| Total equity | 635 278 | 1 365 872 | 621 066 |
| Employees | 2 | 2 | 2 |
| Proposed dividend | — | 1 000 000 | 300 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.